New research in JNCCN—Journal of the National Comprehensive Cancer Network finds that more than 80% of therapies tested in Phase III oncology trials did not achieve meaningful clinical benefit in […]
Protecting patients was at the forefront of presentations and other discussions during ACRP’s 2021 virtual conference yesterday (September 30), with speakers and attendees swapping case studies and best practices to […]
An international group of cancer researchers led by the National Cancer Research Institute’s (NCRI’s) Cellular Molecular Pathology Initiative (CMPath) has published guidance to address the variability in how pathology (the […]
Lessons learned from a new survey about what motivates and retains patients in rare disease trials could have much wider applications in other clinical trials, according to those who conducted […]
“The FDA doesn’t call to ask if it’s a good time for an inspection,” Neala Lane, Associate Director, Quality Improvement Office at Indiana University told attendees of ACRP’s Virtual 2021 […]